Szekeres David Leslie
SEC insider (Form 3/4/5 filer). CIK 0001602459. President at Connect Biopharma Holdings Ltd (CNTB) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 18, 2025. Located in LA JOLLA, CA.
Companies Szekeres David Leslie has filed insider reports for
- Connect Biopharma Holdings Ltd (CNTB): Officer, President
- GRI Bio, Inc. (GRI): Director
Szekeres David Leslie
CIK: 0001602459
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 18, 2025GRI
GRI Bio, Inc.
AwardDirectStock Option (Right to Buy)
39.9K shares- - Aug 26, 2025GRI
GRI Bio, Inc.
AwardDirectStock Option (Right to Buy)
10.3K shares- - Aug 13, 2025GRI
GRI Bio, Inc.
AwardDirectStock Option (Right to Buy)
7.5K shares- - Jan 23, 2025GRI
GRI Bio, Inc.
AwardDirectStock Option (Right to Buy)
51.9K shares at avg. $0.69-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 18, 2025 |  GRI GRI Bio, Inc. | Award Stock Option (Right to Buy) | 39,897 | - | - | Direct |
| Aug 26, 2025 | GRI GRI Bio, Inc. | Award Stock Option (Right to Buy) | 10,276 | - | - | Direct |
| Aug 13, 2025 | GRI GRI Bio, Inc. | Award Stock Option (Right to Buy) | 7,545 | - | - | Direct |
| Jan 23, 2025 | GRI GRI Bio, Inc. | Award Stock Option (Right to Buy) | 51,937 | $0.69 | - | Direct |
1-4 of 4 transactions